John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$251M |
| 2 |
Eli Lilly
LLY
|
+$246M |
| 3 |
Cisco
CSCO
|
+$226M |
| 4 |
Chevron
CVX
|
+$224M |
| 5 |
Mastercard
MA
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$262M |
| 2 |
XYZ
Block Inc
XYZ
|
+$236M |
| 3 |
Target
TGT
|
+$228M |
| 4 |
TJX Companies
TJX
|
+$222M |
| 5 |
Roku
ROKU
|
+$221M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 15.24% |
| 3 | Consumer Discretionary | 8.56% |
| 4 | Financials | 8.41% |
| 5 | Industrials | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
CALL
Ryder
R
$9.44B
| $339K | ﹤0.01% |
4,100
-900
| -18% | -$69.3K |
|
3552
Jack in the Box
JACK
$320M
| $338K | ﹤0.01% |
3,469
-49,787
| -93% | -$5.19M |
|
|
SLNO
3553
DELISTED
Soleno Therapeutics
SLNO
| $338K | ﹤0.01% |
24,390
+9,840
| +68% | +$137K |
|
|
BZUN
3554
CALL
Baozun
BZUN
$165M
| $337K | ﹤0.01% |
19,200
+2,100
| +12% | +$51.6K |
|
3555
Paysign
PAYS
$798M
| $337K | ﹤0.01% |
124,965
-114,875
| -48% | -$308K |
|
3556
Electromed
ELMD
$326M
| $335K | ﹤0.01% |
30,943
-7,283
| -19% | -$87.5K |
|
3557
CALL
FIVE9
FIVN
$2.41B
| $335K | ﹤0.01% |
2,100
-12,600
| -86% | -$2.3M |
|
3558
NMI Holdings
NMIH
$3.41B
| $334K | ﹤0.01% |
14,766
-50,748
| -77% | -$1.12M |
|
3559
CALL
Qualys
QLYS
$6.09B
| $334K | ﹤0.01% |
3,000
+1,000
| +50% | +$110K |
|
3560
Xenetic Biosciences
XBIO
$8.95M
| $334K | ﹤0.01% |
+16,307
| New | +$444K |
|
|
FEED
3561
ENvue Medical Inc
FEED
$4.27M
| $333K | ﹤0.01% |
+74
| New | +$328K |
|
3562
CALL
Ovintiv
OVV
$17.8B
| $332K | ﹤0.01% |
10,100
-600
| -6% | -$16.6K |
|
3563
PUT
Tenet Healthcare
THC
$21.9B
| $332K | ﹤0.01% |
+5,000
| New | +$355K |
|
3564
Bank First Corp
BFC
$1.7B
| $331K | ﹤0.01% |
4,677
-911
| -16% | -$63.5K |
|
3565
Pennant Group
PNTG
$1.34B
| $331K | ﹤0.01% |
11,798
-1,492
| -11% | -$48.8K |
|
3566
CALL
LiveRamp
RAMP
$2.29B
| $331K | ﹤0.01% |
+7,000
| New | +$316K |
|
3567
Apple Hospitality REIT
APLE
$3.95B
| $330K | ﹤0.01% |
+21,000
| New | +$315K |
|
|
PDM
3568
Piedmont Realty Trust
PDM
$1.24B
| $330K | ﹤0.01% |
+18,960
| New | +$345K |
|
|
FTCH
3569
PUT
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $330K | ﹤0.01% |
8,800
-9,700
| -52% | -$430K |
|
3570
PUT
Bank of Montreal
BMO
$121B
| $329K | ﹤0.01% |
+3,300
| New | +$332K |
|
|
BZUN
3571
Baozun
BZUN
$165M
| $329K | ﹤0.01% |
+18,746
| New | +$461K |
|
3572
PUT
Ubiquiti
UI
$34.9B
| $329K | ﹤0.01% |
1,100
-100
| -8% | -$30.9K |
|
3573
Certara
CERT
$1.24B
| $328K | ﹤0.01% |
+9,900
| New | +$299K |
|
3574
Scorpio Tankers
STNG
$3.87B
| $328K | ﹤0.01% |
17,675
-168,908
| -91% | -$2.82M |
|
|
PSB
3575
DELISTED
PS Business Parks, Inc.
PSB
| $328K | ﹤0.01% |
+2,095
| New | +$324K |
|
Similar funds
John Overdeck's Q3 2021 Portfolio in Review
As of Q3 2021, John Overdeck held 4,966 positions worth $44.7B, up 1.5% from $44.1B the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
John Overdeck deployed $1.71B of net new capital in Q3 2021, opening 996 new positions and adding to 1,597 existing holdings. Its largest new stake was PayPal: 884,227 shares worth $230M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Block Inc, an estimated $236M trimmed.
- John Overdeck's largest Q3 2021 buy was PayPal: 884,227 shares worth $230M.
- John Overdeck added most to Cisco in Q3 2021, an estimated $226M increase.
- John Overdeck's biggest Q3 2021 reduction was Block Inc, cutting an estimated $236M.
- John Overdeck fully exited Pfizer in Q3 2021, selling an estimated $262M.
- John Overdeck's ten largest holdings make up 5.2% of its $44.7B portfolio in Q3 2021.
- John Overdeck opened 996 new positions and closed 790 in Q3 2021.
- John Overdeck's portfolio value rose 1.5% quarter-over-quarter to $44.7B.
Based on Two Sigma Investments's 13F filing for Q3 2021, filed 15 Nov 2021.